⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31366816 | 1.00 | — | — | |
| SCHEMBL1108358 | 0.84 | — | — | |
| SCHEMBL94635 | 0.77 | — | — | |
| SCHEMBL5711927 | 0.77 | — | — | |
| SCHEMBL74028 | 0.75 | — | — | |
| SCHEMBL30366996 | 0.75 | — | — | |
| SCHEMBL28448539 | 0.74 | CD44 (0.58) | — | |
| Hydrochloric Acid SCHEMBL17110965 | 0.74 | CD44 (0.58) | — | |
| SCHEMBL28450972 | 0.74 | CD44 (0.58) | — | |
| Charcoal, Activated SCHEMBL29548810 | 0.74 | CD44 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115477583-B | Method for preparing chiral alpha-acyloxy-beta, gamma-unsaturated ester compound | 中国科学院化学研究所 | 2024-03-19 | — | — | CN | claimed |
| CN-115477583-A | Method for preparing chiral alpha-acyloxy-beta, gamma-unsaturated ester compound | 中国科学院化学研究所 | 2022-12-16 | — | — | CN | claimed |
| CN-101318938-B | Method for synthesizing quinoxaline derivant | UNIV SUZHOU | 2010-08-25 | — | — | CN | claimed |
| CN-101318938-A | Method for synthesizing quinoxaline derivant | UNIV SOOCHOW (CN) | 2008-12-10 | — | — | CN | claimed |
| CN-115477583-B | Method for preparing chiral alpha-acyloxy-beta, gamma-unsaturated ester compound | 中国科学院化学研究所 | 2024-03-19 | — | — | CN | disclosed |
| US-11772085-B2 | Far superior oxidation catalysts based on macrocyclic compounds | CARNEGIE MELLON UNIVERSITY (US) | 2023-10-03 | — | — | US | disclosed |
| CN-115477583-A | Method for preparing chiral alpha-acyloxy-beta, gamma-unsaturated ester compound | 中国科学院化学研究所 | 2022-12-16 | — | — | CN | disclosed |
| EP-4015511-A1 | OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS | CARNEGIE MELLON UNIVERSITY (US) | 2022-06-22 | — | — | EP | disclosed |
| CN-114206390-A | Transmucosal administration of drugs | 电化株式会社 | 2022-03-18 | — | — | CN | disclosed |
| EP-3578176-A1 | NON-PLATINUM-BASED ANTI-CANCER COMPOUNDS FOR USE IN TARGETED CHEMOTHERAPY | Lu, Qing-Bin (CA) | 2019-12-11 | — | — | EP | disclosed |
| EP-2935215-B1 | RADIOSENSITIZER COMPOUNDS FOR USE IN COMBINATION WITH RADIATION | LU QING BIN (CA) | 2019-11-13 | — | — | EP | disclosed |
| EP-3055287-B1 | NON-PLATINUM-BASED ANTI-CANCER COMPOUNDS FOR USE IN TARGETED CHEMOTHERAPY | LU QING BIN (CA) | 2019-11-06 | — | — | EP | disclosed |
| WO-2008118122-A2 | COMPOUNDS AND AMYLOID PROBES THEREOF FOR THERAPEUTIC AND IMAGING USES | MOLECULAR NEUROIMAGING, LLC (US) | 2008-10-02 | — | — | WO | disclosed |
| EP-1274711-B1 | NEW AZA-INDOLYL DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2006-05-17 | — | — | EP | disclosed |
| US-6583134-B2 | Tricyclic aza-indolyl derivatives substituted with ethylamine group is useful for treating central nervous system disorder,cardiovascular disorder, gastrointestinal disorders, diabetes insipidus, and particularly useful for obesity | HOFFMAN-LA ROCHE INC. | 2003-06-24 | — | — | US | disclosed |
| EP-1274711-A1 | NEW AZA-INDOLYL DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2003-01-15 | — | — | EP | disclosed |
| US-20010025039-A1 | Aza- indolyl derivatives for treating obesity | HOFFMANN-LA ROCHE INC. | 2001-09-27 | — | — | US | disclosed |
| WO-2001066548-A1 | NEW AZA-INDOLYL DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2001-09-13 | — | — | WO | disclosed |
| EP-1132389-A1 | New aza-indolyl derivatives for the treatment of obesity | VERNALIS RESEARCH LIMITED (GB) | 2001-09-12 | — | — | EP | disclosed |
| WO-1994026264-A1 | (4-ALKOXYPYRAN-4-YL) SUBSTITUTED ARYLALKYLARYL-, ARYLALKENYLARYL-, AND ARYLALKYNYLARYLUREA INHIBITORS OF 5-LIPOXYGENASE | ABBOTT LABORATORIES (US) | 1994-11-24 | — | — | WO | disclosed |